PASG

Passage Bio, Inc.

A clinical-stage gene therapy company developing one-time treatments for rare brain and nervous-system diseases. Founded in 2019 as a spinout of the University of Pennsylvania's Gene Therapy Program, it builds on the work of gene-therapy pioneer James Wilson. Its name comes from "passaging" — the lab process of growing and purifying the harmless viruses that carry therapeutic genes into cells. Its lead programs target rare disorders such as GM1 gangliosidosis and Krabbe disease.

Recent Activity

Show $

2020Q2

1 sell

ArrowMark PartnersEXIT

-62.0K shares

ArrowMark PartnersEXIT

-62.0K shares

2020Q1

1 buy

ArrowMark PartnersNEW

+62.0K shares

ArrowMark PartnersNEW

+62.0K shares